HUT64084A - Process for producing pharmaceutical compositions comprising quininogenase inhibitors - Google Patents
Process for producing pharmaceutical compositions comprising quininogenase inhibitors Download PDFInfo
- Publication number
- HUT64084A HUT64084A HU93610A HU61093A HUT64084A HU T64084 A HUT64084 A HU T64084A HU 93610 A HU93610 A HU 93610A HU 61093 A HU61093 A HU 61093A HU T64084 A HUT64084 A HU T64084A
- Authority
- HU
- Hungary
- Prior art keywords
- group
- alkyl
- phe
- dpro
- arg
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909019558A GB9019558D0 (en) | 1990-09-07 | 1990-09-07 | Enzyme inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9300610D0 HU9300610D0 (en) | 1993-05-28 |
HUT64084A true HUT64084A (en) | 1993-11-29 |
Family
ID=10681831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU93610A HUT64084A (en) | 1990-09-07 | 1991-09-02 | Process for producing pharmaceutical compositions comprising quininogenase inhibitors |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0652893A1 (fi) |
JP (1) | JPH06501461A (fi) |
AU (1) | AU8438791A (fi) |
CA (1) | CA2090858A1 (fi) |
FI (1) | FI930946A (fi) |
GB (1) | GB9019558D0 (fi) |
HU (1) | HUT64084A (fi) |
IE (1) | IE913120A1 (fi) |
MC (1) | MC2313A1 (fi) |
NO (1) | NO930731L (fi) |
PT (1) | PT98885A (fi) |
WO (1) | WO1992004371A1 (fi) |
ZA (1) | ZA917096B (fi) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9103612D0 (sv) * | 1991-12-04 | 1991-12-04 | Astra Ab | New peptide derivatives |
US5374623A (en) * | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
US6984627B1 (en) | 1993-06-03 | 2006-01-10 | Astrazeneca Ab | Peptide derivatives |
SE9301911D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptide derivatives |
US5783563A (en) * | 1993-06-03 | 1998-07-21 | Astra Aktiebolag | Method for treatment or prophylaxis of venous thrombosis |
SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
GB9318637D0 (en) * | 1993-09-08 | 1993-10-27 | Ferring Res Ltd | Enzyme inhibitors |
US5486623A (en) | 1993-12-08 | 1996-01-23 | Prototek, Inc. | Cysteine protease inhibitors containing heterocyclic leaving groups |
SE9404196D0 (sv) * | 1994-12-02 | 1994-12-02 | Astra Ab | New antithrombotic formulation |
US6025472A (en) * | 1994-12-21 | 2000-02-15 | Corvas International, Inc. | N-substituted glycine derivatives as enzyme inhibitors |
US5696231A (en) * | 1994-12-21 | 1997-12-09 | Corvas International, Inc. | N-substituted glycine derivatives as enzyme inhibitors |
US6586466B2 (en) | 1995-10-30 | 2003-07-01 | Smithkline Beecham Corporation | Carbohydrazide-protease inhibitors |
SK56798A3 (en) | 1995-10-30 | 1998-12-02 | Smithkline Beecham Corp | Protease inhibitors, pharmaceutical composition containing them and their use |
TW541316B (en) * | 1995-12-21 | 2003-07-11 | Astrazeneca Ab | Prodrugs of thrombin inhibitors |
IL139162A0 (en) | 1998-04-24 | 2001-11-25 | Dimensional Pharm Inc | Amidinohydrazone, alkoxyguanidine and aminoguanidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
YU42401A (sh) | 1998-12-14 | 2003-12-31 | Ortho-Mcneil Pharmaceuticals Inc. | Supstituisani heterociklični acil-tripeptidi korisni kao modulatori receptora trombina |
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
EP1158996A4 (en) | 1999-02-18 | 2005-01-12 | Kaken Pharma Co Ltd | NEW AMID DERIVATIVES AS GROWTH HORMONE SECRETION CONVEYORS |
WO2001034599A1 (en) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Protease inhibitors |
JP2003513972A (ja) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害剤 |
US6534498B1 (en) | 1999-11-10 | 2003-03-18 | Smithkline Beecham Corporation | Protease inhibitors |
EA005893B1 (ru) | 2000-03-21 | 2005-06-30 | Смитклайн Бичам Корпорейшн | Ингибиторы протеаз |
GB0205527D0 (en) * | 2002-03-08 | 2002-04-24 | Ferring Bv | Inhibitors |
CA2491611A1 (en) | 2002-07-03 | 2004-01-15 | Bio Science International, Inc. | Peptides comprising aromatic d-amino acids and methods of use |
FR2846969A1 (fr) * | 2002-11-08 | 2004-05-14 | Salles Jean Pierre | Nouveaux vecteurs moleculaires amphiphiles fluorocarbones a usage biomedical et medical |
EP1736465A4 (en) * | 2004-03-31 | 2009-06-17 | Ajinomoto Kk | ANILINE DERIVATIVES |
GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
GB2494851A (en) | 2011-07-07 | 2013-03-27 | Kalvista Pharmaceuticals Ltd | Plasma kallikrein inhibitors |
GB201212081D0 (en) | 2012-07-06 | 2012-08-22 | Kalvista Pharmaceuticals Ltd | New polymorph |
IL239682B (en) | 2013-01-08 | 2018-10-31 | Kalvista Pharmaceuticals Ltd | History of benzylamine and 2-(aminomethyl)pyridine |
GB201300304D0 (en) | 2013-01-08 | 2013-02-20 | Kalvista Pharmaceuticals Ltd | Benzylamine derivatives |
GB2510407A (en) | 2013-02-04 | 2014-08-06 | Kalvista Pharmaceuticals Ltd | Aqueous suspensions of kallikrein inhibitors for parenteral administration |
MX363689B (es) | 2013-05-23 | 2019-03-29 | Kalvista Pharmaceuticals Ltd | Derivados de heterociclicos. |
MX366498B (es) | 2013-08-14 | 2019-07-11 | Kalvista Pharmaceuticals Ltd | Inhibidores de calicreina plasmatica. |
GB2517908A (en) | 2013-08-14 | 2015-03-11 | Kalvista Pharmaceuticals Ltd | Bicyclic inhibitors |
TWI636047B (zh) | 2013-08-14 | 2018-09-21 | 英商卡爾維斯塔製藥有限公司 | 雜環衍生物 |
EP3204352B1 (en) | 2014-10-06 | 2020-07-01 | Cortexyme, Inc. | Inhibitors of lysine gingipain |
GB201421085D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | New enzyme inhibitors |
GB201421083D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | Enzyme inhibitors |
GB201421088D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | New enzyme inhibitors |
CA3004095A1 (en) | 2015-11-09 | 2017-05-18 | Cortexyme, Inc. | Inhibitors of arginine gingipain |
RU2020140891A (ru) | 2016-05-31 | 2021-02-10 | Калвиста Фармасьютикалз Лимитед | Производные пиразола в качестве ингибиторов калликреина |
GB201609607D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts |
GB201609603D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide |
WO2018053353A1 (en) | 2016-09-16 | 2018-03-22 | Cortexyme, Inc. | Ketone inhibitors of lysine gingipain |
CN107043338B (zh) * | 2017-03-24 | 2018-09-25 | 东华大学 | 一类5-氨基酮戊酸衍生物及其制备方法和应用 |
CN107011217B (zh) * | 2017-03-24 | 2018-08-14 | 东华大学 | 一类脂溶性5-氨基酮戊酸衍生物及其制备方法和应用 |
IL274557B1 (en) | 2017-11-29 | 2024-05-01 | Kalvista Pharmaceuticals Ltd | Dosage forms containing a plasma kallikrein inhibitor |
GB201719881D0 (en) | 2017-11-29 | 2018-01-10 | Kalvista Pharmaceuticals Ltd | Solid forms of plasma kallikrein inhibitor and salts thereof |
GB201910116D0 (en) | 2019-07-15 | 2019-08-28 | Kalvista Pharmaceuticals Ltd | Treatments of hereditary angioedema |
GB201910125D0 (en) | 2019-07-15 | 2019-08-28 | Kalvista Pharmaceuticals Ltd | Treatments of angioedema |
CN114206852A (zh) | 2019-08-09 | 2022-03-18 | 卡尔维斯塔制药有限公司 | 血浆激肽释放酶抑制剂 |
GB201918994D0 (en) | 2019-12-20 | 2020-02-05 | Kalvista Pharmaceuticals Ltd | Treatments of diabetic macular edema and impaired visual acuity |
GB2591730A (en) | 2019-12-09 | 2021-08-11 | Kalvista Pharmaceuticals Ltd | New polymorphs |
TW202228686A (zh) | 2020-10-15 | 2022-08-01 | 英商卡爾維斯塔製藥有限公司 | 血管性水腫之治療 |
EP4232031A1 (en) | 2020-10-23 | 2023-08-30 | Kalvista Pharmaceuticals Limited | Treatments of angioedema |
WO2022172006A1 (en) | 2021-02-09 | 2022-08-18 | Kalvista Pharmaceuticals Limited | Treatments of hereditary angioedema |
WO2023002219A1 (en) | 2021-07-23 | 2023-01-26 | Kalvista Pharmaceuticals Limited | Treatments of hereditary angioedema |
EP4288036A1 (en) | 2022-04-27 | 2023-12-13 | Kalvista Pharmaceuticals Limited | Formulations of a plasma kallikrein inhibitor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0009010B1 (en) * | 1978-07-18 | 1983-03-02 | Kabi AB | Bradykinin inhibiting tripeptide derivatives, process for their preparation and pharmaceutical preparations containing them |
US4563305A (en) * | 1981-01-07 | 1986-01-07 | University Of Miami | Radiolabelled substrates for assaying mammalian enzymes |
US4835253A (en) * | 1987-04-03 | 1989-05-30 | The University Hospital | Specific inhibitors of tissue kallikrein |
ZA897514B (en) * | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
-
1990
- 1990-09-07 GB GB909019558A patent/GB9019558D0/en active Pending
-
1991
- 1991-09-02 CA CA002090858A patent/CA2090858A1/en not_active Abandoned
- 1991-09-02 EP EP91915557A patent/EP0652893A1/en not_active Withdrawn
- 1991-09-02 AU AU84387/91A patent/AU8438791A/en not_active Abandoned
- 1991-09-02 JP JP3514802A patent/JPH06501461A/ja active Pending
- 1991-09-02 WO PCT/GB1991/001479 patent/WO1992004371A1/en not_active Application Discontinuation
- 1991-09-02 HU HU93610A patent/HUT64084A/hu unknown
- 1991-09-02 MC MC912313D patent/MC2313A1/xx unknown
- 1991-09-05 IE IE312091A patent/IE913120A1/en unknown
- 1991-09-06 PT PT98885A patent/PT98885A/pt not_active Application Discontinuation
- 1991-09-06 ZA ZA917096A patent/ZA917096B/xx unknown
-
1993
- 1993-02-26 NO NO93930731A patent/NO930731L/no unknown
- 1993-03-03 FI FI930946A patent/FI930946A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
GB9019558D0 (en) | 1990-10-24 |
NO930731L (no) | 1993-05-07 |
FI930946A0 (fi) | 1993-03-03 |
CA2090858A1 (en) | 1992-03-08 |
PT98885A (pt) | 1992-08-31 |
MC2313A1 (fr) | 1993-09-27 |
AU8438791A (en) | 1992-03-30 |
IE913120A1 (en) | 1992-03-11 |
ZA917096B (en) | 1992-04-29 |
HU9300610D0 (en) | 1993-05-28 |
WO1992004371A1 (en) | 1992-03-19 |
FI930946A (fi) | 1993-04-26 |
NO930731D0 (no) | 1993-02-26 |
EP0652893A1 (en) | 1995-05-17 |
JPH06501461A (ja) | 1994-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT64084A (en) | Process for producing pharmaceutical compositions comprising quininogenase inhibitors | |
AU600226B2 (en) | Novel peptidase inhibitors | |
Martinez et al. | Synthesis and biological activities of some pseudo-peptide analogs of tetragastrin: the importance of the peptide backbone | |
US6130315A (en) | Peptidase inhibitors | |
US6287840B1 (en) | Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups | |
FI67539C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara peptidyl-ng-karboxyl-arginaldehyder | |
FI88398C (fi) | Foerfarande foer framstaellning av peptidanaloger | |
EP0275101A2 (en) | Novel peptidase inhibitors | |
JPH03502578A (ja) | 7/7a因子活性部位阻害剤 | |
DE69434070T2 (de) | Kininogen-inhibitoren | |
US5422342A (en) | 2,3-disubstituted isoxazolidines, agents containing them and their use | |
US5521158A (en) | Pseudopeptide bradykinin receptor antagonists | |
WO1993008211A1 (en) | Tripeptide derivative anti-inflammatory agents | |
JPS60243098A (ja) | ホモフエ8を含有するレニン阻害剤 | |
CA1249396A (en) | Partially retro-inverted decapeptide as a specific renin inhibitor with high resistance to enzymatic hydrolysis | |
PL177914B1 (pl) | Nowe pochodne difluoropentapeptydu i środek farmaceutyczny | |
EP0762887B1 (en) | Acylated enol derivatives as prodrugs of elastase inhibitors | |
JPS61155395A (ja) | retro逆転ペプチド及びその合成法 | |
WO1988005049A1 (en) | Novel compounds | |
JP2004083427A (ja) | 環状ヘキサペプチド及びプロテアソーム阻害剤 | |
KR0142195B1 (ko) | 고나도리베린의 경쟁적 길항제 | |
DE3108322A1 (de) | Chromogenes enzymsubstrat | |
JPH02209865A (ja) | 3―チオプロピオン酸誘導体の製造法 | |
KR840002357B1 (ko) | S-(아실아미도아실)메르캅토아실 프롤린류의 제조방법 | |
DE2327634A1 (de) | Nonapeptide und verfahren zu deren herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee |